EUVIMED · CrossrefZeitschrift
Current Psychopharmacology
ISSN 2211-5560 · Bentham Science Publishers Ltd.
Neueste Artikel
Acute Repetitive Seizures from Pathophysiology to Novel Treatment Options
Therapeutic Potential of Herbs in Modulating Neurochemical Pathways in Depression: A Preclinical Perspective
Programmed Cell Death-1 (PD-1) Signalling and Neurotransmitter Dynamics: Implications for Neuroprotection
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Psychiatric Polypharmacy, Etiology and Potential Consequences
Nicotine and Tobacco Particulate Self-Administration: Effects of Mecamylamine, SCH23390 and Ketanserin Pretreatment
Pharmacotherapy and the Psychobiological Model of Personality: Implications for DSM-5
Pathological Gambling: Neuropsychopharmacology and Treatment
The Neurochemical Anatomy of Runway Acquisition and Extinction
The Neuroanatomy, Etiopathogenesis, and Novel Therapeutic Targets in Depressive Disorders
Semaglutide’s Neuropharmacological Effects: From Glycemic Regulation and Weight Loss to Potential Implications in Substance Use Disorders – A Narrative Review
Psilocybin in the Management of Substance Use Disorders: A Summary of Current Evidence
Hippocampal Serotonin and Responses to Immobilization Stress in Rats Treated with Metformin
Rapid Metabolism of Monthly Extended-Release Buprenorphine Formulation: A Case Report
Have We Placed the Cart Before the Horse by Using Alpha-2A Agonists to Treat Rejection Sensitivity Dysphoria in ADHD?
A Literature-Based Study of Tardive Dyskinesia- From Pathogenesis to Treatment
Positive Psychotic Symptoms after Escitalopram Treatment in a Female Adolescent with Peroxisome Spectrum Disorder Due to PEX-6 Gene Mutation
Potential of Andrographolide and Andrographis paniculata Extracts for the Management of Diabetes-associated Psychopathologies: Current Status
Marine Natural Products as Novel Treatments for Alzheimer's Disease
The Present Difficulties and Potential Benefits of Dopaminergic Agents in Parkinson's Disease Treatment
Metaforest Algorithm Insights: Predictors of Nocebo Response in ADHD
Enzymes and Alzheimer's Disease: Pioneering Drug Development Strategies
Navigating Hormonal Disruptions in Neuroleptic Drug Therapy: Current Insights and Obstacles
Neuroinflammation in the Genesis of Epilepsy
Exploring Aripiprazole Analogs as Antipsychotic Agents: Scaffold Morphing Approach, ADMET Profile Predictions, and Molecular Docking Studies
Precision Medicine and Antipsychotics in Parkinson’s Disease: A Focus on MAO-B Pathway Modulation
Advancing Alzheimer's Treatment: Unleashing the Power of Donanemab and Quantum Computing for Enhanced Patient Outcomes
A Review of the Evidence Surrounding Popular Cognitive Enhancers
A Review of Lithium Effects on Inhibitory Control in Executive Tasks
Targeted Nanomedicines and Advanced Therapies in Epilepsy Treatment
EUVIMED